l-carnitine tmao nature medicine 2013 koeth Effects of choline metabolite—trimethylamine N-oxide on immunometabolism in inflammatory bowel disease γ–Butyrobetaine is a pro-atherogenic intermediate
Butyrobetaine is a pro atherogenic intermediate in gut microbial metabolism of L carnitine to TMAO PMC Gut Metabolite Trimethylamine N Oxide in Atherosclerosis: From Mechanism to Therapy Frontiers The gutbrain axis and trimethylamine N oxide: an emergent biomarker in neurological diseases ScienceDirect JCI l Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans Gut Microbiota Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target PMC
Pay in 4 interest-free payments of $6.03 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11




